Monday, June 09, 2014 7:07:46 AM
IMO, Ken sold the license to MedGen so he could fund his own startup to launch his own product with his own patent. Who would you rather buy the product from, the inventor or a person licensed to use the patent?!?!? $$$$$$$$$$$$$$$
This is a major WIN WIN for Ken since he can use the funds from MedGen (if they are successful bringing the product to market) to fund his own product coming to market. GENIUS. And we all know, every great inventor never licenses ALL of their great ideas. I feel Ken has something special or a major breakthrough that he can add to his own product and shoot right past any of MedGen's attempts when the time is right.
IMO, Ken bought this FOGC shell in order to raise and support brining the Lactose Freedom product to market quickly after a lackluster attempt at crowd funding on MedStartr. When investors spread the word about Manzo's product I feel this ticker will explode in market cap and give him a MUCH better chance at actually brining this product to market.
Here is a link to MDIN which purchased a license to use Ken's patent for, from what I gather, 500 million shares
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100536483
For the people that refuse to believe the obvious...
http://ihaveabridgetosellyou.com
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM